Versant Venture Management, LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001560009 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 7, 2021

Total Value: $513M (100.0% shares, 0.0% debt)

Holdings (11)

CRSP CRISPR Therapeutics AG 36.9%

Value $189M Shares 1,554,960 Est. Cost $40.26 Unrealized +275.0%

— Passage Bio, Inc. 16.9%

Value $86.7M Shares 4,959,769 Est. Cost $17.48 Unrealized —

— Aligos Therapeutics, Inc. 14.6%

Value $74.87M Shares 3,292,339 Est. Cost $27.65 Unrealized —

— Adverum Biotechnologies, Inc. 9.7%

Value $49.97M Shares 5,068,233 Est. Cost $9646.10 Unrealized —

— Gritstone Oncology, Inc. 8.2%

Value $41.97M Shares 4,450,638 Est. Cost $7767.86 Unrealized —

CRNX Crinetics Pharmaceuticals, Inc. 6.0%

Value $31.03M Shares 2,030,616 Est. Cost $17.05 Unrealized -9.1%

— Akero Therapeutics, Inc. 3.5%

Value $17.92M Shares 617,727 Est. Cost $21200.00 Unrealized —

— Flexion Therapeutics, Inc. 2.3%

Value $11.73M Shares 1,310,169 Est. Cost $10.41 Unrealized —

— Aprea Therapeutics, Inc 1.3%

Value $6.424M Shares 1,259,662 Est. Cost $38780.00 Unrealized —

— CymaBay Therapeutics, Inc. 0.5%

Value $2.469M Shares 543,753 Est. Cost $9871.60 Unrealized —

— Clovis Oncology, Inc. 0.1%

Value $715K Shares 101,855 Est. Cost $56000.00 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CRSP	CRISPR Therapeutics AG	1,554,960	$189M	36.9%	$40.26	+275.0%	Common Shares	H17182108
—	Passage Bio, Inc.	4,959,769	$86.7M	16.9%	$17.48	—	Common Stock	702712100
—	Aligos Therapeutics, Inc.	3,292,339	$74.87M	14.6%	$27.65	—	Common Stock	01626L105
—	Adverum Biotechnologies, Inc.	5,068,233	$49.97M	9.7%	$9646.10	—	Common Stock	00773U108
—	Gritstone Oncology, Inc.	4,450,638	$41.97M	8.2%	$7767.86	—	Common Stock	39868T105
CRNX	Crinetics Pharmaceuticals, Inc.	2,030,616	$31.03M	6.0%	$17.05	-9.1%	Common Stock	22663K107
—	Akero Therapeutics, Inc.	617,727	$17.92M	3.5%	$21200.00	—	Common Stock	00973Y108
—	Flexion Therapeutics, Inc.	1,310,169	$11.73M	2.3%	$10.41	—	Common Stock	33938J106
—	Aprea Therapeutics, Inc	1,259,662	$6.424M	1.3%	$38780.00	—	Common Stock	03836J102
—	CymaBay Therapeutics, Inc.	543,753	$2.469M	0.5%	$9871.60	—	Common Stock	23257D103
—	Clovis Oncology, Inc.	101,855	$715K	0.1%	$56000.00	—	Common Stock	189464100